Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
10.22
+0.23 (2.30%)
At close: Jul 19, 2024, 4:00 PM
10.17
-0.05 (-0.49%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Profound Medical Revenue

Profound Medical had revenue of $5.33M in the twelve months ending March 31, 2024, with 2.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.40M with 4.20% year-over-year growth. In the year 2023, Profound Medical had annual revenue of $5.41M with 10.99% growth.

Revenue (ttm)
$5.33M
Revenue Growth
+2.49%
P/S Ratio
46.84
Revenue / Employee
$40,688
Employees
131
Market Cap
249.66M USD

Revenue Chart

* The company reports in CAD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.41M536.14K10.99%
Dec 31, 20224.88M-492.89K-9.18%
Dec 31, 20215.37M-359.10K-6.27%
Dec 31, 20205.73M2.54M79.79%
Dec 31, 20193.19M1.26M65.30%
Dec 31, 20181.93M-1.93M-49.97%
Dec 31, 20173.85M--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AirSculpt Technologies 197.72M
Codexis 74.23M
AVITA Medical 51.50M
Utah Medical Products 49.04M
Nanobiotix 40.23M
Zevra Therapeutics 28.01M
Senseonics Holdings 23.30M
Atai Life Sciences 277.00K
Revenue Rankings